CD-Chex CD117® Plus by Streck

Manufacturer Streck  |  Available Worldwide
CD-Chex CD117 Plus is a flow cytometry control that provides assay values for CD117, CD25 and CD71 on abnormal and total leukocytes. 


CD-Chex CD117<sup>®</sup> Plus by Streck product image
CD-Chex CD117® Plus
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

CD-Chex CD117 Plus is a ready-to-use control for evaluating CD117, CD25 and CD71 expression by flow cytometry. Developed to resemble peripheral blood leukocytes often found in a hematolymphoid neoplastic patient sample, CD-Chex CD117 provides percent-positive values for CD117, CD25 and CD71 on abnormal and total leukocytes. Abnormal leukocytes are distinguishable from normal leukocytes based on light scatter properties and low CD45 expression. 

CD-Chex CD117 is a positive procedural control designed to monitor reagent staining, erythrocyte lysis, sample preparation and instrument performance and is compatible with BD® Biosciences and Beckman Coulter® flow cytometry systems. 

Features 

  • Only commercially available control assayed for CD117, CD25 and CD71 
  • Resembles an abnormal peripheral blood patient sample 
  • Compatible with BD Biosciences and Beckman Coulter flow cytometry systems 
  • 30-day open-vial stability; 90-day closed-vial stability 

Benefits 

  • Aids in meeting the quality requirements for leukemia and lymphoma immunophenotyping 
  • Manufacturer established assay ranges – no need to verify range per CAP requirements 
  • Reduces the need for labs to hold and validate patient samples for use as a control 
  • Access to STATS®, Streck’s free interlaboratory quality control program for peer group data comparison 
  • For Research Use Only. Not for use in diagnostic procedures.